Skip to main content

Procainamide Hydrochloride Injection Shortage

Last Updated: April 25, 2018
Status: Resolved

Reason for the Shortage
    • Pfizer had procainamide injection on shortage due to manufacturing delays.
    • Nexus Pharmaceuticals launched procainamide injection in October 2017.
Available Products
    • Procainamide Hydrochloride injection, Amphastar, 100 mg/mL, 10 mL Luer Lock syringe, 5 count, NDC 76329-3399-05
    • Procainamide Hydrochloride injection, Nexus Pharmaceuticals, 100 mg/mL, 10 mL multiple dose vial, 10 count, NDC 14789-0900-10
    • Procainamide Hydrochloride injection, Nexus Pharmaceuticals, 500 mg/mL, 2 mL multiple dose vial, 10 count, NDC 14789-0900-02
    • Procainamide Hydrochloride injection, Pfizer, 100 mg/mL, 10 mL vial, 25 count, NDC 00409-1902-01
    • Procainamide Hydrochloride injection, Pfizer, 500 mg/mL, 2 mL vial, 25 count, NDC 00409-1903-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated April 25, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 2, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer